Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02340000 · ClinicalTrials.gov registry record · Phase 4

Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate

A Phase 4 study of Sinusitis, sponsored by Albany Medical College.

Completed
Registry status
Phase 4
Development phase
315
Enrollment target
1
Study location

NCT02340000 is a Phase 4 study of Sinusitis that has completed, run by Albany Medical College. The registered enrollment target is 315 participants, above the 104-participant average among 12 other Sinusitis trials with a reported enrollment target (203% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02340000, a Phase 4 study of Sinusitis, has completed, sponsored by Albany Medical College.

COMPLETED
Registry status
Phase 4
Development phase
315 participants
Enrollment target
1
Study location

Study Summary

The aim is to determine if high-dose amoxicillin/clavulanate is more effective than standard-dose amoxicillin/clavulanate in treating acute bacterial sinusitis in adults seen at a primary care office.

Conditions Studied

Interventions

  • DRUG standard dose amoxicillin/clavulanate
  • DRUG high dose amoxicillin/clavulanate

Study Locations (1)

New York

  • Albany Medical Center Internal Medicine and Pediatrics - Latham

Trial Details

FieldValue
Enrollment Target 315 participants
Start Date 2014-11-18
Est. Completion 2017-02-27
Phase Phase 4

Sponsor

Albany Medical College

52 total trials

What the Registry Record Tells You About NCT02340000

The ClinicalTrials.gov registry entry for NCT02340000 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 104-participant average among 12 other Sinusitis trials with a reported enrollment target (203% higher). The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which standard dose amoxicillin/clavulanate is the first listed.

NCT02340000 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02340000 about?

NCT02340000 is a clinical study titled "Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate". The aim is to determine if high-dose amoxicillin/clavulanate is more effective than standard-dose amoxicillin/clavulanate in treating acute bacterial sinusitis in adults seen at a primary care office.

What is the current status of trial NCT02340000?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 315 participants. The study started on 2014-11-18. Estimated completion is 2017-02-27.

What conditions does trial NCT02340000 study?

This clinical trial studies the following conditions: Sinusitis.

What interventions are being tested in trial NCT02340000?

The interventions under investigation include: standard dose amoxicillin/clavulanate (DRUG), high dose amoxicillin/clavulanate (DRUG).

Who is sponsoring clinical trial NCT02340000?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02340000 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sinusitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.